Relationship Between Acyl and Desacyl Ghrelin Levels with Insulin Resistance and Body Fat Mass in Type 2 Diabetes Mellitus
Pu Zang,Cui-Hua Yang,Jun Liu,Hai-Yan Lei,Wei Wang,Qing-Yu Guo,Bin Lu,Jia-Qing Shao
DOI: https://doi.org/10.2147/DMSO.S368770
2022-09-08
Abstract:Pu Zang, 1, &ast Cui-Hua Yang, 1, &ast Jun Liu, 2 Hai-Yan Lei, 2 Wei Wang, 1 Qing-Yu Guo, 1 Bin Lu, 1 Jia-Qing Shao 1 1 Department of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, People's Republic of China; 2 Department of Endocrinology, Jinling Hospital, Southern Medical University, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jia-Qing Shao, Department of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, People's Republic of China, Tel +86-25-80860354, Email Purpose: Although strong evidence suggests that ghrelin plays an important role in regulating energy balance, the effects of acylated ghrelin (AG) and deacylated ghrelin (DAG) on fat mass are largely undefined. This study aimed to investigate the differential associations of both forms of ghrelin with insulin resistance and body fat mass in patients with type 2 diabetes mellitus (T2DM). Patients and Methods: A total of 162 patients with type 2 diabetes were recruited and classified based on BMI and visceral fat area (VFA) as VFA normal group (n = 78), normal-BMI VFA obesity group (n = 20) and high-BMI VFA obesity group (n = 64). VFA and subcutaneous fat area (SFA) were detected by bioelectrical impedance analysis. Blood samples were collected to measure fasting glucose, insulin, lipids, AG and DAG levels after clinical examination. Results: Compared with VFA normal group, DAG levels were significantly lower (421.7 ± 106.0 and 388.7 ± 96.5 pg/mL vs 524.4 ± 141.5 pg/mL, P < 0.01) in the two VFA obesity groups. No significant difference was found in AG levels within three groups. Among all subjects, BMI, VFA, SFA, fasting insulin and HOMA-IR were negatively correlated with DAG but positively with AG/DAG ratio (P < 0.01). In contrast, AG was positively correlated with HOMA-IR and fasting glucose (P < 0.01). Multiple stepwise regression analysis showed that fasting glucose was the independent factor of AG, VFA and HOMA-IR were the independent factors related to DAG. Conclusion: DAG levels have a strong negative association with excess body fat mass and insulin resistance, whereas AG levels are closely related to elevated blood glucose levels in T2DM patients. Keywords: acylated ghrelin, deacylated ghrelin, body fat mass, insulin resistance, type 2 diabetes mellitus The pathogenesis of type 2 diabetes mellitus (T2DM) is known to involve impaired insulin secretion and insulin resistance (IR). IR is closely related to metabolic syndrome, which is mainly characterized by obesity and metabolic dysfunction leading to increased cardiovascular mortality and morbidity. 1 With a significant increase in the global obesity population, IR is prevalent and plays a key pathophysiological role in patients with metabolic syndrome. Thus, it is necessary to explore effective methods to improve insulin resistance and obesity in diabetic individuals. Ghrelin is a 28-amino acid hormone that is mainly secreted from stomach A-like cells. 2 It is divided into acylated ghrelin (AG) and deacylated ghrelin (DAG) according to whether its N-terminal serine residue is acylated. 3 Ghrelin circulates in vivo mainly as deacylated ghrelin corresponding to more than 80% of the hormone. 4 A growing body of evidence suggests that ghrelin has a role in insulin resistance and development of type 2 diabetes. 5,6 Considering that total ghrelin (T-Ghr) is mainly composed of DAG form, T-Ghr and DAG values likely lead to the same conclusions in terms of differences among groups and associations with insulin resistance and glycometabolism in previous studies. 7–9 Insulin resistance and obesity are closely related to low circulating levels of total ghrelin (T-Ghr) or DAG. 7–10 However, the potential differential effects of two circulating ghrelin forms on energy balance in humans are largely undefined. Ghrelin circulating in acylated form has been reported to have a negative influence on pancreatic insulin secretion and lipid metabolism. 11,12 On the other hand, DAG also has important metabolic activities, which presumably are GHSR-independent, including the ability to counteract the effect of AG in certain circumstances. 13–15 Studies have shown different results in the circulating levels of AG and DAG in obese individuals, reflected not only at baseline but also at postprandial levels. 6,14,15 Since acyl and des-acyl ghrelin appear to have opposite actions and interact with different receptors, it is important to note th -Abstract Truncated-